Peering Into Legend Biotech's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Legend Biotech's short interest has decreased by 8.84%, with 10.08 million shares sold short, representing 10.62% of its float. This is higher than its peers' average of 5.90%. The decrease in short interest may indicate a more bullish sentiment.
September 06, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Legend Biotech's short interest has decreased by 8.84%, with 10.08 million shares sold short, representing 10.62% of its float. This is higher than its peers' average of 5.90%. The decrease in short interest may indicate a more bullish sentiment.
The decrease in short interest suggests a potential shift in market sentiment towards a more bullish outlook for Legend Biotech. With short interest still higher than peers, it indicates that while sentiment is improving, caution remains. This could lead to upward pressure on the stock price if sentiment continues to improve.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100